Gilead CEO John Martin pockets $19 million in stock sale

Gilead Sciences Inc. Chairman and CEO John Martin made nearly $19 million by selling 282,242 shares Monday at nearly 10 times the price at which he exercised options to buy the shares...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.